Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy - 1 Sept 2003

Krüüner Annika, Jureen Pontus, Levina Klavdia, Ghebremichael Solomon, Hoffner Sven

Abstract excerpt

It is generally thought that there is full cross-resistance in Mycobacterium tuberculosis between the aminoglycoside drugs kanamycin and amikacin. However, kanamycin resistance and amikacin susceptibility were seen in 43 of 79 (54%) multidrug-resistant Estonian isolates, indicating that there mig...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amikacin
Share to Antibiotics, Antitubercular
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estonia

Share to Genes, Bacterial

Share to Kanamycin

Share to Mycobacterium tuberculosis

Share to Tuberculosis

Source

Open in PubMed Open full text

Identifiers

PMID: 12937004
DOI: 10.1128/AAC.47.9.2971-2973.2003
PMCID: PMC182599

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12937004-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.PMID 12937004Read ↗

High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.Semantic proximity Read ↗

Potential Efficacy of Streptomycin in Amikacin-resistant <i>Mycobacterium avium-intracellulare</i> Complex Pulmonary DiseaseSemantic proximity Read ↗

Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.Semantic proximity Read ↗

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.Semantic proximity Read ↗

Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosisSemantic proximity Read ↗

Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis.Semantic proximity Read ↗

Polymorphisms Associated with Resistance and Cross-Resistance to Aminoglycosides and Capreomycin in Mycobacterium tuberculosis Isolates from South Korean Patients with Drug-Resistant TuberculosisSemantic proximity Read ↗

Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.